Column Iceland - October 20, 2026
An NMT for health?
If you know what an NMT phone is, or, even more so, if you've ever used one, it's likely that you are formerly young. Slightly less so in Iceland, where well into the 2000s lots of the cool kids still had NMT phones in their jeeps. Your trusty Nokia 3310 could go several days on a charge, but drive away from a town or up a valley and the coverage quickly got spotty. With an NMT, though, you could head up toward the highlands or the upper reaches of a river and never be out of touch.
Column - July 15, 2026
The golden age of scientific breakthroughs in Alzheimer’s disease diagnosis and treatment is now
Presentations at the Alzheimer's Association International Conference (AAIC) show a field moving rapidly forward both with regard to treatments and diagnostics.
Column - March 23, 2026
Why Iceland is well placed to answer the challenges confronting the healthtech and AI transformation
There isn't enough high-quality and deep multimodal data, on enough people, in benchmarkable structures that participants and practitioners trust, to build the large general healthcare models required. And that's where Iceland comes in.
Column Iceland - November 24, 2025
Innovation island
Following in the footsteps of their predecessors, the new generation of Icelandic life science entrepreneurs are converting their old problems of isolation and a limited workforce into a model system for developing novel therapies and tools to streamline healthcare.
Column - October 20, 2025
Who should lead the transformation towards sustainable healthcare?
With healthcare systems under unsurmountable pressure and patient care at risk, embracing a holistic approach to sustainable healthcare is critical to protecting the future of healthcare.
Column - October 7, 2025
Preparedness and the crucial role of life science
When the next pandemic, climate-driven health crisis, or antimicrobial threat strikes will we be ready? True preparedness is not measured in stockpiles or contingency plans alone. It lies in our ability to harness life science as a cornerstone of resilience – connecting human, animal, and environmental health to build societies that can withstand the crises of tomorrow.
Commentaries
Commentary – September 14, 2026
Can patients drive advanced evidence generation?
Lessons from two rare kidney diseases
Commentary – September 1, 2026
“The technology exists. Ukraine needs it”: Inside a Swedish surgeon’s mission to Ukraine
Rickard Brånemark, Chief Medical and Scientific Officer at Integrum, has traveled to Ukraine eight times to train surgeons in an advanced Swedish implant technology for amputees. The need, he writes, is difficult to overstate – and the question now is how quickly the technology can be scaled up to meet it.
Commentary – July 14, 2026
Pyrogen Testing in Transition – New Technologies and Evolving Requirements
Both the detection of pyrogens in general and that of bacterial endotoxins in particular are undergoing a period of transition.
Commentary – October 29, 2025
What is OMOP and how can it benefit the life science industry?
What if health data was stored in the exact same format, using the exact same coding and conventions at each university hospital in the Nordics? Then a researcher could write one analysis script and run it everywhere. Results can be compared or combined instantly, without moving sensitive data. Studies that once were impossible or took months to complete could be done in weeks, all while preserving privacy.
Commentary – September 16, 2025
There is no science without talent
Why the supply of skills and competence matters for Nordic global competitiveness.
Commentary – June 2, 2025
Preparedness for a new era – Clear roles and Nordic collaboration
In December last year, Sweden’s National Board of Health and Welfare and the Swedish Civil Contingencies Agency concluded that the country’s pharmaceutical stockpiles are insufficient to cope with a crisis or war. That is a serious conclusion. Their report outlines 130 measures to address this, 40 of which are considered to be high priority. But the key question is: how will the stockpiling work in practice?
Commentary – December 11, 2024
AI and the 2024 Nobel Prizes: A Revolutionary Moment for Life Sciences
The 2024 Nobel Prizes in Chemistry and Physics reflect the revolutionary impact of artificial intelligence (AI) on life sciences. These awards, celebrating advancements in protein design and neural networks, demonstrate how AI is transforming how we approach drug discovery, personalized medicine, and healthcare management.
Commentary – July 3, 2024
Commentary: Navigating the Obesity Market
Challenges and Funding Dilemmas from an International and Nordic Perspective. It is no secret that obesity is one of the biggest public health challenges of the 21st century and is one of the leading causes of preventable death globally. It’s estimated that 18% of the global population is obese, with the prevalence of obesity in […]
Commentary – June 19, 2023
Pharmaceuticals in the Baltic Sea Environment
Pharmaceutical ingredients have been detected in the environment – on every continent. The same properties that make pharmaceuticals effective increase the risk of undesired effects in the environment.
Commentary – March 22, 2023
Oligos – The medicines of the future?
What if we could silence certain genes to treat a wide range of medical conditions, from genetic conditions to infectious diseases, and even cancer? It may sound like science fiction, but for some rare diseases it’s already a reality through the use of oligonucleotide therapeutics, sometimes referred to as the medicines of the future.